Romosuzumab used to treat a 29-year-old patient with anorexia nervosa related osteoporosis - A case report.

Osteoporosis and decreased bone density is a frequent complication of anorexia nervosa (AN). As of yet, there have been no studies of accomplished treatment of AN-related osteoporosis with romosuzumab, a monoclonal antibody to sclerostin. We report the first case of a premenopausal, 29-year old patient in Switzerland with decreased bone density and osteoporotic fractures due to anorexia nervosa, who completed the treatment with romosuzumab.

Long-term Follow-up of Canaliculotomies after Canaliculitis.

Background: Canaliculitis is often misdiagnosed. There are several conservative and surgical treatment options.

Patients And Methods: Retrospective analysis of 14 canaliculotomies in 10 patients with canaliculitis.